Dr. Bartolome R. Celli, MD
Pulmonology (Pulmonary Disease Physician)
At a glance
- In the NPI registry since
- 2005
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
MA license 39732
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 8 companies reported 30 payments worth $78,888 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $19,140 |
|---|---|
| Chiesi USA, Inc. | $15,840 |
| Genzyme Corporation | $12,102 |
| GlaxoSmithKline, LLC. | $10,951 |
| Sanofi US Services Inc. | $6,513 |
| Verona Pharma, Inc. | $6,512 |
| F. Hoffmann-la Roche AG | $5,581 |
| AstraZeneca UK Limited | $2,250 |
| Consulting Fee | $77,844 |
|---|---|
| Travel and Lodging | $576 |
| Food and Beverage | $468 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Chiesi USA, Inc. Feb 13, 2025 | Consulting Fee | $15,840 |
| Genzyme Corporation Mar 1, 2025 | Consulting Fee | $11,904 |
| Verona Pharma, Inc. Jul 7, 2025 | Consulting Fee Ohtuvayre · Pulmonary/Respiratory Diseases | $4,712 |
| GlaxoSmithKline, LLC. Oct 1, 2025 | Consulting Fee | $4,225 |
| Sanofi US Services Inc. Aug 25, 2025 | Consulting Fee | $3,507 |
| AstraZeneca Pharmaceuticals LP Nov 26, 2025 | Consulting Fee | $3,150 |
| Sanofi US Services Inc. Mar 17, 2025 | Consulting Fee | $3,006 |
| GlaxoSmithKline, LLC. Aug 8, 2025 | Consulting Fee | $2,925 |
| F. Hoffmann-la Roche AG Sep 27, 2025 | Consulting Fee | $2,640 |
| AstraZeneca Pharmaceuticals LP Oct 10, 2025 | Consulting Fee BREZTRI · Respiratory | $2,417 |
All 26 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 26, 2025 | Consulting Fee | $3,150 |
| AstraZeneca Pharmaceuticals LP Oct 10, 2025 | Consulting Fee BREZTRI · Respiratory | $2,417 |
| AstraZeneca Pharmaceuticals LP Oct 9, 2025 | Consulting Fee TEZSPIRE · Respiratory | $2,275 |
| AstraZeneca UK Limited Oct 7, 2025 | Consulting Fee | $2,250 |
| AstraZeneca Pharmaceuticals LP Oct 3, 2025 | Consulting Fee | $2,228 |
| GlaxoSmithKline, LLC. Oct 1, 2025 | Consulting Fee | $4,225 |
| Verona Pharma, Inc. Sep 30, 2025 | Consulting Fee Ohtuvayre · Pulmonary/Respiratory Diseases | $1,800 |
| F. Hoffmann-la Roche AG Sep 27, 2025 | Consulting Fee | $2,640 |
| GlaxoSmithKline, LLC. Sep 12, 2025 | Consulting Fee | $1,625 |
| AstraZeneca Pharmaceuticals LP Sep 10, 2025 | Consulting Fee TEZSPIRE · Respiratory | $2,275 |
| Sanofi US Services Inc. Aug 25, 2025 | Consulting Fee | $3,507 |
| GlaxoSmithKline, LLC. Aug 8, 2025 | Consulting Fee | $2,925 |
| Verona Pharma, Inc. Jul 7, 2025 | Consulting Fee Ohtuvayre · Pulmonary/Respiratory Diseases | $4,712 |
| AstraZeneca Pharmaceuticals LP Jul 2, 2025 | Consulting Fee TEZSPIRE · Respiratory | $177 |
| AstraZeneca Pharmaceuticals LP Jun 27, 2025 | Consulting Fee | $1,800 |
| AstraZeneca Pharmaceuticals LP Jun 27, 2025 | Consulting Fee | $1,463 |
| AstraZeneca Pharmaceuticals LP Jun 25, 2025 | Consulting Fee BREZTRI · Respiratory Company’s descriptionResearch Related Service | $1,611 |
| F. Hoffmann-la Roche AG May 17, 2025 | Consulting Fee | $1,815 |
| GlaxoSmithKline, LLC. Apr 9, 2025 | Travel and Lodging travel to Cancun, Mexico · in-kind | $576 |
| F. Hoffmann-la Roche AG Apr 8, 2025 | Consulting Fee | $990 |
| Sanofi US Services Inc. Mar 17, 2025 | Consulting Fee | $3,006 |
| GlaxoSmithKline, LLC. Mar 4, 2025 | Consulting Fee | $1,600 |
| Genzyme Corporation Mar 1, 2025 | Consulting Fee | $11,904 |
| Chiesi USA, Inc. Feb 13, 2025 | Consulting Fee | $15,840 |
| AstraZeneca Pharmaceuticals LP Jan 21, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $1,343 |
| AstraZeneca Pharmaceuticals LP Jan 3, 2025 | Consulting Fee | $269 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.